clinical trial design complexity. The results suggest that targeted regulatory innovation can shorten R&D periods without …

This study investigates how enhanced regulation can promote innovation, focusing on the impacts of a significant … recognized the improvement in drug innovation, as reflected in stock price adjustments post new drug registrations after the … latecomers could boost their innovation potential by adopting specific, effective regulatory practices from frontier countries …

Traditional value of medical innovation models estimate the benefits of a new treatment to individuals who fall sick ex …-post. However, economic theory suggests medical innovation has additional benefits ex-ante - before susceptible individuals know … whether or not they will fall sick. This paper presents a model for estimating the ex-ante value of new medical innovation …

elements of U.S. innovation policy. Innovation institutions — the legal arrangements that structure incentives for production …-addictive treatments for chronic pain. Although innovation policy does not bear all the blame for the opioid wave that has washed over … communities across the country, innovation institutions are bound up in the ongoing epidemic to a degree that so far has gone …

, competition, corruption and product innovation in light of both our data and the new Directive 2014/24/EU …

surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health …